ANIKA THERAPEUTICS Stock Price
$13.75 
Change:
-0.75 -2.59% Volume:
5,375
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 14.53 | Todays Low: 13.65 | Open: 14.5 | Last Close: 14.39
52 Wk High: 16.26 | 52 Wk Low: 9.24 | Todays Pivot: 13.98 | Pre market open: 8.49
Sector: 
Online News For Anika Therapeutics
|
Anika Therapeutics Reports First-Quarter 2013 Financial Results - Business Wire (press release)
Wed, 01 May 2013 21:33BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter ended March 31, 2013.
|
|
Anika Therapeutics Q1 13 Earnings Conference Call At 9:00 AM ET - NASDAQ
Thu, 02 May 2013 12:01(RTTNews.com) - Anika Therapeutics Inc. ( ANIK ) will host a conference call at 9:00 AM ETMay 2, 2013, to discuss its Q1 13 earnings results. To access the live webcast, log on at www.anikatherapeutics.com. A call can be accessed by dialing 866-825 ...
|
|
XenoPort Candidate Disappoints - Zacks.com
Tue, 21 May 2013 20:45Pfizer's ( PFE - Analyst Report ) Neurontin competes with Horizant for the PHN indication. XenoPort currently carries a Zacks Rank #3 (Hold). Right now, Anika Therapeutics, Inc. ( ANIK - Snapshot Report ) looks attractive with a Zacks Rank #1 (Strong Buy).
|
|
Anika executives take 40 percent compensation cut - Boston Business Journal (blog)
Fri, 26 Apr 2013 22:19Enlarge. The three top executives at Anika Therapeutics Inc. (Nasdaq:ANIK) saw an overall 40 percent reduction in total compensation last year from 2011 after its single-injection osteoarthritis pain relief treatment was not approved by the U.S. Food ...
|
|
Biogen's Hemophilia BLA Accepted - Analyst Blog - NASDAQ
Mon, 20 May 2013 14:28At present, companies like Anika Therapeutics Inc. ( ANIK ), Alexion Pharmaceuticals, Inc. ( ALXN ) and Alkermes ( ALKS ) look well-positioned. While Anika is a Zacks Rank #1 (Strong Buy) stock, Alkermes and Alexion are Zacks Rank #2 (Buy) stocks.
|
|
A look back at 25 years of the Globe 100 - Boston Globe
Sun, 19 May 2013 05:14But developments in Massachusetts labs, aided by a doubling of the National Institutes of Health budget in the late 1990s, helped propel a new crop of life sciences companies such as Biogen Idec Inc. and Anika Therapeutics Inc. “We've seen a tremendous ...
|
ANIK Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Anika Therapeutics quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ANIK to choose from. Visit here to build your stock quote widget »
